General Practitioners' Coping Strategies for Polypharmacy in Elderly Patients with Multimorbidity

doi:10.12114/j.issn.1007-9572.2020.00.325

Abstract

Abstract: Polypharmacy-induced adverse reactions and hazards are common in elderly patients with multimorbidity.At the same time，the economic burden is increased.We summarized the status and various hazards of polypharmacy in this group，and based on this，proposed that formulating a rational diagnostic and therapeutic regimen should be using Beers Criteria and medication appropriateness index（MAI）after comprehensive patient assessment by the general practice team with at least a pharmacist included.And the regimen should be modified timely according to general practitioner-delivered community-based follow-up results.Moreover，medication safety should be monitored.In addition，to reduce polypharmacy，non-drug interventions such as strengthened medical care and physical therapy can be used，so that the quality of life of the patients may be improved.

Key words: Comorbidity, Polypharmacy, Aged, General practice, General practitioners, Coping strategies

摘要： 老年患者常多病共存，用药种类繁多，易引起药物不良反应（ADR），产生诸多危害，同时加重了患者经济负担。本文总结了老年共病患者多重用药的现状及多种危害，提出组建由药师参与的全科诊疗团队对老年共病患者实行综合评估，应用Beers标准及药物适宜性指数（MAI）为其制定合理的诊疗方案。全科医师应做好老年共病患者的社区随访工作，及时调整用药方案，监测用药的安全性，采用加强医疗照护、物理疗法等非药物措施减少多重用药，从而提高患者的生活质量。

关键词: 共病现象, 多种药物疗法, 老年人, 全科医学, 全科医生, 应对策略

YAN Wei,CHEN Xue,DING Jing. General Practitioners' Coping Strategies for Polypharmacy in Elderly Patients with Multimorbidity　[J]. Chinese General Practice, 2020, 23(15): 1859-1863. DOI: 10.12114/j.issn.1007-9572.2020.00.325.
闫巍,陈雪,丁静. 全科医师面对老年共病患者多重用药的应对策略[J]. 中国全科医学, 2020, 23(15): 1859-1863. DOI: 10.12114/j.issn.1007-9572.2020.00.325.

References

［1］闫巍，李瑞，王杰萍，等．北京市某三级医院综合科老年共病住院患者临床特点分析［J］．中国全科医学，2018，21（14）：1648-1656.DOI：10.3969/j.issn.1007-9572.2018.00.119.
YAN W，LI R，WANG J P，et al．Clinical characteristics of elderly inpatients with multimorbidity in geriatric department of a tertiary hospital in Beijing［J］．Chinese General Practice，2018，21（14）：1648-1656.DOI：10.3969/j.issn.1007-9572.2018.00.119.
［2］HUON J F，LENAIN E，LEGUEN J，et al．How drug use by French elderly patients has changed during the last decade［J］．Drugs Real World Outcomes，2015，2（4）：327-333．DOI：10.1007/s40801-015-0041-6.
［3］CHARLESWORTH C J，SMIT E，LEE D S，et al．Polypharmacy among adults aged 65 years and older in the United States：1988—2010［J］．J Gerontol A Biol Sci Med Sci，2015，70（8）：989-995．DOI：10.1093/gerona/glv013.
［4］刘淼，李嘉琦，吕宪玉，等．≥80岁老年人多重用药现况及影响因素分析［J］．中国公共卫生，2017，33（3）：412-414.
LIU M，LI J Q，LYU X Y，et al．Prevalence and influencing factors of polypharmacy among persons aged 80 years or older［J］．Chinese Journal of Public Health，2017，33（3）：412-414.
［5］唐杨琛，顾朋颖，靳松，等．80岁以上老年人多重用药的临床观察［J］．中国临床保健杂志，2018，21（2）：156-159．DOI：10.3969/J.issn.1672-6790.2018.02.004.
TANG Y C，GU P Y，JIN S，et al．Clinical observation of polypharmacy in the elderly aged over 80 years［J］．Chinese Journal of Clinical Healthcare，2018，21（2）：156-159．DOI：10.3969/J.issn.1672-6790.2018.02.004.
［6］孙雪林，穆林，陈頔，等．门诊老年患者用药情况分析［J］．中华老年医学杂志，2018（5）：561-564.
SUN X L，MU L，CHEN D，et al．Analysis of outpatient prescription medications in the elderly［J］．Chinese Journal of Geriatrics，2018（5）：561-564.
［7］马翔宇，侯宁.老年人潜在不适当用药调查分析［J］．中国医院用药评价与分析，2019，19（8）：1017-1020．DOI：10.14009/j.issn.1672-2124.2019.08.036.
MA X Y，HOU N.Investigation and analysis of potential inappropriate drug application among the elderly［J］．Evaluation and Analysis of Drug-Use in Hospitals of China，2019，19（8）：1017-1020．DOI：10.14009/j.issn.1672-2124.2019.08.036.
［8］谢吉科，颜妍，陈朋，等．北京清华长庚医院门诊老年患者多重用药调查及潜在不适当用药分析［J］．临床药物治疗杂志，2018，16（11）：52-55，60.
XIE J K，YAN Y，CHEN P，et al．The investigation of multiple drug use and potential inappropriate medication use analysis in elderly outpatients in Beijing Tsinghua Changgung Hospital［J］．Clinical Medication Journal，2018，16（11）：52-55，60.
［9］闫巍，王杰萍，张洪波，等．老年共病患者在诊疗中面临的问题及应对策略［J］．中国全科医学，2018，21（3）：261-264．DOI：10.3969/j.issn.1007-9572.2017.00.207.
YAN W，WANG J P，ZHANG H B，et al．Challenges and solutions for elderly patients with multimorbidity during receiving management in China［J］．Chinese General Practice，2018，21（3）：261-264．DOI：10.3969/j.issn.1007-9572.2017.00.207.
［10］王鹏，王青，崔云静，等．老年住院患者潜在不适当用药与共病、衰弱、失能的相关性［J］．中华老年多器官疾病杂志，2018，17（11）：820-824．DOI：10.11915/j.issn.1671-5403.2018.11.188.
WANG P，WANG Q，CUI Y J，et al．Association between potentially inappropriate medication and comorbidity，frailty and disability in the hospitalized elderly patients［J］．Chinese Journal of Multiple Organ Diseases in the Elderly，2018，17（11）：820-824．DOI：10.11915/j.issn.1671-5403.2018.11.188.
［11］GóMEZ C，VEGA-QUIROGA S，BERMEJO-PAREJA F，et al．Polypharmacy in the elderly：a marker of increased risk of mortality in a population-based prospective study（NEDICES）［J］．Gerontology，2015，61（4）：301-309．DOI：10.1159/000365328.
［12］SGANGA F，VETRANO D L，VOLPATO S，et al．Physical performance measures and polypharmacy among hospitalized older adults：results from the CRIME study［J］．J Nutr Health Aging，2014，18（6）：616-621．DOI：10.1007/s12603-014-0029-z.
［13］李灵艳，王青，张少景，等．老年住院患者共病及多重用药与衰弱关系的分析［J］．北京医学，2018，40（1）：8-11．DOI：10.15932/j.0253-9713.2018.01.003.
LI L Y，WANG Q，ZHANG S J，et al．Analysis of the relationship of comorbidity and polypharmacy with frailty in elderly inpatients［J］．Beijing Medical Journal，2018，40（1）：8-11．DOI：10.15932/j.0253-9713.2018.01.003.
［14］闫雪莲，刘晓红.优化老年人药物治疗策略［J］．中华全科医师杂志，2018，17（5）：337-340．DOI：10.3760/cma.j.issn.1671-7368.2018.05.001.
YAN X L，LIU X H.Optimizing medication strategies in elderly patients［J］．Chinese Journal of General Practitioners，2018，17（5）：337-340．DOI：10.3760/cma.j.issn.1671-7368.2018.05.001.
［15］Australian and New Zealand Society for Geriatric Medicine Position Statement Abstract：prescribing in older people［EB/OL］．（2018-08-03）［2019-12-13］．https：//onlinelibrary.wiley.com/doi/abs/10.1111/ajag.12577.
［16］方力争，徐志杰.《澳大利亚与新西兰老年医学会立场声明：老年人处方》解读［J］．中国全科医学，2019，22（7）：747-752．DOI：10.12114/j.issn.1007-9572.2019.07.001.
FANG L Z，XU Z J.Interpretation of Australian and New Zealand Society for Geriatric Medicine Position Statement of prescribing in older people［J］．Chinese General Practice，2019，22（7）：747-752．DOI：10.12114/j.issn.1007-9572.2019.07.001.
［17］贾博颖，周双，张晓琳，等．处方精简在老年患者中的可行性与安全性分析［J］．中国临床药理学杂志，2019，35（21）：2768-2772．DOI：10.13699/j.cnki.1001-6821.2019.21.032.
JIA B Y，ZHOU S，ZHANG X L，et al．Feasibility and effect analysis of deprescribing in older adults［J］．The Chinese Journal of Clinical Pharmacology，2019，35（21）：2768-2772．DOI：10.13699/j.cnki.1001-6821.2019.21.032.
［18］李晨，林欣，陈孟莉.老年患者多重用药处方精简干预临床效果的Meta分析［J］．中华老年多器官疾病杂志，2019，18（3）：161-168．DOI：10.11915/j.issn.1671-5403.2019.03.032.
LI C，LIN X，CHEN M L.Impact of deprescribing interventions on clinical outcomes in the elderly patients：a Meta-analysis［J］．Chinese Journal of Multiple Organ Diseases in the Elderly，2019，18（3）：161-168．DOI：10.11915/j.issn.1671-5403.2019.03.032.
［19］张宏，张亚同，王钰，等．9种慢性病的临床指南中的潜在药物相互作用研究［J］．中国药房，2019，30（3）：289-293.
ZHANG H，ZHANG Y T，WANG Y，et al．Study on the potential drug interaction in clinical guidelines for 9 chronic diseases［J］．China Pharmacy，2019，30（3）：289-293.
［20］许夏燕，郑桂梅，王振兴，等．社区药师门诊对老年慢病患者药物治疗管理（MTM）的服务实践［J］．中国药师，2018，21（7）：1214-1217．DOI：10.3969/j.issn.1008-049X.2018.07.021.
XU X Y，ZHENG G M，WANG Z X，et al．Service practice of community pharmacist clinic in medicine treatment management for elderly patients with chronic diseases［J］．China Pharmacist，2018，21（7）：1214-1217．DOI：10.3969/j.issn.1008-049X.2018.07.021.
［21］卢成华，路丹，金鑫，等．老年共病患者药物治疗适宜性评估研究［J］．中华老年医学杂志，2018，37（1）：57-61．DOI：10.3760/cma.j.issn.0254-9026.2018.01.014.
LU C H，LU D，JIN X，et al．Evaluation of the reliability of Beers criteria and medication appropriateness index in multimorbid elderly patients with polypharmacy［J］．Chinese Journal of Geriatrics，2018，37（1）：57-61．DOI：10.3760/cma.j.issn.0254-9026.2018.01.014.
［22］SWANOSKI M T，LITTLE M M，ST HILL C A，et al．Potentially inappropriate medication prescribing in US older adults with selected chronic conditions［J］．Consult Pharm，2017，32（9）：525-534．DOI：10.4140/TCP.n.2017.525.
［23］舒冰，刘玉龙，张圣雨，等．老年人潜在不适当用药评价工具2019年版Beers标准解读［J］．中国全科医学，2019，22（33）：4041-4046.
SHU B，LIU Y L，ZHANG S Y，et al．Interpretation of 2019 Beers criteria for potentially inappropriate medication use in older adults［J］．Chinese General Practice，2019，22（33）：4041-4046.
［24］By The American Geriatrics Society Beers Criteria? Update Expert Panel.American geriatrics society 2019 updated AGS beers criteria? for potentially inappropriate medication use in older adults［J］．J Am Geriatr Soc，2019，67（4）：674-694．DOI：10.1111/jgs.15767.
［25］张丹，李根，李莉，等．临床药师参与1例老年患者的精准用药实践［J］．中国药业，2019，28（5）：90-92．DOI：10.3969/j.issn.1006-4931.2019.05.031.
ZHANG D，LI G，LI L，et al．Clinical pharmacist's participation in the practice of precise drug use in an elderly patient［J］．China Pharmaceuticals，2019，28（5）：90-92．DOI：10.3969/j.issn.1006-4931.2019.05.031.
［26］曾平，闫雪莲，朱鸣雷，等．老年人药物重整的应用效果分析［J］．中华老年多器官疾病杂志，2016，15（8）：575-578．DOI：10.11915/j.issn.1671-5403.2016.08.136.
ZENG P，YAN X L，ZHU M L，et al．Application of medication reconciliation in a geriatric ward and its effect analysis［J］．Chinese Journal of Multiple Organ Diseases in the Elderly，2016，15（8）：575-578．DOI：10.11915/j.issn.1671-5403.2016.08.136.
［27］By The American Geriatrics Society Beers Criteria Update Expert Panel.American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults［J］．J Am Geriatr Soc，2015，63（11）：2227-2246．DOI：10.1111/jgs.13702.
［28］孙树森，朱斌，赵志刚.老年人潜在的不适当药物使用标准解读：2015年版比尔斯Beers标准［J］．药品评价，2015，12（24）：15-22，45．DOI：10.3969/j.issn.1672-2809.2015.24.002.
SUN S S，ZHU B，ZHAO Z G.Potentially inappropriate medication use in older adults：2015 Beers criteria［J］．Drug Evaluation，2015，12（24）：15-22，45．DOI：10.3969/j.issn.1672-2809.2015.24.002.
［29］邱珊娇，黄文静.基于Beers标准的社区老年共病患者多重用药治疗方案一例分析［J］．中国全科医学，2019，22（36）：4532-4534.
QIU S J，HUANG W J.Using Beers criteria to manage medication regimens for elder patients with multimorbidity in primary care：a case study［J］．Chinese General Practice，2019，22（36）：4532-4534.
［30］刘夏，潘琴，徐迅科，等．基于《中国老年人潜在不适当用药判断标准（2017版）》的老年患者不适当用药评价研究［J］．药学实践杂志，2019，37（3）：283-288．DOI：10.3969/j.issn.1006-0111.2019.03.019.
LIU X，PAN Q，XU X K，et al．Research on potentially inappropriate medication use in elderly patients：based on the Clinical use of criteria of potentially inappropriate medications for older adults in China（2017）［J］．Journal of Pharmaceutical Practice，2019，37（3）：283-288．DOI：10.3969/j.issn.1006-0111.2019.03.019.
［31］闫巍，王杰萍，张洪波，等．连续性健康管理对提高老年共病患者生活质量的重要性分析［J］．中国全科医学，2018，21（27）：3302-3306.
YAN W，WANG J P，ZHANG H B，et al．Importance of performing continuous health management to the elderly patients with multimorbidity in order to improve the quality of life［J］．Chinese General Practice，2018，21（27）：3302-3306.
［32］王秋梅，闫雪莲，刘晓红，等．老年人用药依从性及其相关影响因素分析［J］．中国临床保健杂志，2018，21（2）：148-152.
WANG Q M，YAN X L，LIU X H，et al．Medication adherence and the related influential factors among the elderly patients［J］．Chinese Journal of Clinical Healthcare，2018，21（2）：148-152.
［33］徐倩，白松，冯湘君，等．老年共病与多重用药的应对策略［J］．中国全科医学，2017，20（23）：2823-2826．DOI：10.3969/j.issn.1007-9572.2017.23.004.
XU Q，BAI S，FENG X J，et al．Countermeasures for polypharmacy in the elderly with comorbidity［J］．Chinese General Practice，2017，20（23）：2823-2826．DOI：10.3969/j.issn.1007-9572.2017.23.004.
［34］中国老年保健医学研究会老年内分泌与代谢病分会，中国毒理学会临床毒理专业委员会.老年人多重用药安全管理专家共识［J］．中国糖尿病杂志，2018，26（9）：705-717．DOI：10.3969/j.issn.1006-6187.2018.09.001.

[1]	WANG Tingting, TANG Yong, ZHANG Wenke, LI Zhigang. Research Progress on Exercise Intervention of Hyperuricemia [J]. Chinese General Practice, 2025, 28(30): 3841-3846.
[2]	XU Jialan, YAN Hong, WEN Jun, ZHOU Zitong, WANG Siyu. Prevalence of Potentially Inappropriate Medication in Older Adults with Cancer: a Meta-analysis [J]. Chinese General Practice, 2025, 28(30): 3815-3822.
[3]	LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia. Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(30): 3773-3778.
[4]	ZHAO Wenwen, LI Nuoya, ZHANG Yali, ZHANG Jinjia, ZHANG Min, LIU Hualei, XI Biao, WANG Rongying. Research on Evaluation of Quality Evaluation System of General Practice Faculty in Standardized Clinical Residency Training Bases (General Hospitals) [J]. Chinese General Practice, 2025, 28(25): 3187-3192.
[5]	ZHAI Jiayan, LU Yuan, PAN Ying, YU Dehua. Experience of Introducing Programmatic Assessment in General Practice Clinical Reasoning Courses from Constructivism Learning Theory [J]. Chinese General Practice, 2025, 28(25): 3193-3199.
[6]	JIAO Shuting, ZHAO Yali. Need Analysis of Medical Students for the Introduction to General Practice Course Based on the Kano Model [J]. Chinese General Practice, 2025, 28(25): 3180-3186.
[7]	PAN Qi, REN Jingjing, MA Fanghui, HU Mengjie. Survey of General Practitioners' Cognition and Needs for AI Assisted Diagnosis and Treatment Systems [J]. Chinese General Practice, 2025, 28(25): 3127-3136.
[8]	YU Wenhua, LI Jianguo, DUAN Wenyan, GAO Xuyan, LI Xiaxia, ZHANG Zilong, ZHANG Li, MA Lina. Reliability and Validity of the Function Impairment Screening Tool among Community-dwelling Older Adults [J]. Chinese General Practice, 2025, 28(24): 3000-3004.
[9]	YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058.
[10]	LI Jiaxin, LIU Zhonghui, XIE Shuo, FU Zhifang, SUN Dan, JIAO Hongmei. Trajectory in Biomarkers of Metabolic and Inflammatory States as Early Predictors of Chronic Critical Illness in Aging Patients [J]. Chinese General Practice, 2025, 28(24): 2993-2999.
[11]	BAI Xue, CHEN Qianqian, LI Jie. Innovative Practices in Chronic Disease Management: a New Model for Generalist-Specialist Combination Management of Diabetes and Metabolic Dysfunction-associated Fatty Liver Disease [J]. Chinese General Practice, 2025, 28(23): 2841-2845.
[12]	LI Jinhong, WANG Yu, XU Yaoming, LIU Yang, HOU Jinghui. Exploring the Application Effect of the Joint Outpatient Teaching of General Practice-Specialist-Community Practice Base in Standardized Training of General Practice Residents [J]. Chinese General Practice, 2025, 28(22): 2726-2730.
[13]	CUI Longyan, DAI Gaolanxin, TAO Hongbing. Training Models for General Practitioners with Special Interests: Foreign Experiences and Chinese Insights [J]. Chinese General Practice, 2025, 28(22): 2720-2725.
[14]	ZHAO Can, SHEN Ying, CHEN Peimeng, PENG Houxuan, XI Qian, GU Jinmei, QIN Li, LIANG Ruiying, ZUO Yanli. An Assessment Research on Consultation Competence of RTME Graduates Trained Via the "5+3" Pathway in Township Health Centers in Guangxi Zhuang Autonomous Region [J]. Chinese General Practice, 2025, 28(22): 2731-2739.
[15]	ZHAO Xiaoqing, GUO Tongtong, ZHANG Xinyi, LI Linhong, ZHANG Ya, JI Lihong, DONG Zhiwei, GAO Qianqian, CAI Weiqing, ZHENG Wengui, JING Qi. Construction and Validation of a Risk Prediction Model for Cognitive Impairment in Community-dwelling Older Adults [J]. Chinese General Practice, 2025, 28(22): 2776-2783.